Unlocking the Potential of Cancer Immunotherapy with 3D Immune Cell Killing Assays
Credit : Istock
CAR T-cell therapies have shown impressive results in treating hematological malignancies. However, developing specialized therapies for the treatment of solid tumors still remains a challenge.
3D cell culture models are essential in researching how therapies can infiltrate and remain effective in solid tumor microenvironments. By optimizing 3D cell killing assays using the latest analysis/analytical technologies, researchers can guide and accelerate the engineering of novel therapeutics.
This literature review explores a range of successful assay setups that leverage different analytical technologies.
Download this literature review to discover:
- Different assay setups for 3D killing assays
- High-content analysis, image cytometry and in vivo imaging for 3D killing assays
- Benefits and challenges of the different technologies
Access this Whitepaper for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
